Schedule of Segment Reporting Information, by Segment [Table Text Block] |
Business Segment Information | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | | | September 26, | September 27, | September 26, | September 27, | (In millions) | | 2015 | | 2014 | | 2015 | | 2014 | | | | | | | | | | | | | | | | Revenues | | | | | | | | | | | | | | Life Sciences Solutions | | $ | 1,080.4 | | $ | 1,071.9 | | $ | 3,229.6 | | $ | 3,010.5 | | Analytical Instruments | | | 778.5 | | | 786.5 | | | 2,282.9 | | | 2,349.8 | | Specialty Diagnostics | | | 776.9 | | | 811.8 | | | 2,379.2 | | | 2,480.6 | | Laboratory Products and Services | | | 1,638.2 | | | 1,628.7 | | | 4,844.9 | | | 4,918.6 | | Eliminations | | | (150.8) | | | (127.5) | | | (423.7) | | | (362.7) | | | | | | | | | | | | | | | | | | Consolidated revenues | | | 4,123.2 | | | 4,171.4 | | | 12,312.9 | | | 12,396.8 | | | | | | | | | | | | | | | | Segment Income (a) | | | | | | | | | | | | | | Life Sciences Solutions | | | 332.7 | | | 306.3 | | | 954.9 | | | 850.0 | | Analytical Instruments | | | 146.5 | | | 137.8 | | | 407.8 | | | 399.1 | | Specialty Diagnostics | | | 204.9 | | | 224.3 | | | 646.2 | | | 681.7 | | Laboratory Products and Services | | | 249.6 | | | 246.6 | | | 731.7 | | | 738.3 | | | | | | | | | | | | | | | | | | Subtotal reportable segments (a) | | | 933.7 | | | 915.0 | | | 2,740.6 | | | 2,669.1 | | | | | | | | | | | | | | | | | Cost of revenues charges | | | (0.8) | | | (2.1) | | | (2.5) | | | (326.7) | | Selling, general and administrative charges, net | | | (24.6) | | | (20.3) | | | (35.4) | | | (118.0) | | Restructuring and other (costs) income, net | | | (15.5) | | | 110.6 | | | (67.9) | | | 631.9 | | Amortization of acquisition-related intangible assets | | | (329.9) | | | (362.9) | | | (988.8) | | | (992.4) | | | | | | | | | | | | | | | | | | Consolidated operating income | | | 562.9 | | | 640.3 | | | 1,646.0 | | | 1,863.9 | | Other expense, net (b) | | | (94.8) | | | (101.1) | | | (292.3) | | | (313.8) | | | | | | | | | | | | | | | | | Income from continuing operations before income taxes | | $ | 468.1 | | $ | 539.2 | | $ | 1,353.7 | | $ | 1,550.1 | | | | | | | | | | | | | | | | Depreciation | | | | | | | | | | | | | | Life Sciences Solutions | | $ | 38.4 | | $ | 37.1 | | $ | 106.7 | | $ | 97.4 | | Analytical Instruments | | | 9.9 | | | 9.4 | | | 28.6 | | | 29.0 | | Specialty Diagnostics | | | 18.8 | | | 19.4 | | | 54.6 | | | 57.4 | | Laboratory Products and Services | | | 30.7 | | | 26.9 | | | 85.0 | | | 79.9 | | | | | | | | | | | | | | | | Consolidated depreciation | | $ | 97.8 | | $ | 92.8 | | $ | 274.9 | | $ | 263.7 | | | | | | | | | | | | | | | | (a) | Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles. | | (b) | The company does not allocate other expense, net to its segments. | | | | | | | | | | | | | | | |
|
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] |
Business Segment Information | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | | | September 26, | September 27, | September 26, | September 27, | (In millions) | | 2015 | | 2014 | | 2015 | | 2014 | | | | | | | | | | | | | | | | Revenues | | | | | | | | | | | | | | Life Sciences Solutions | | $ | 1,080.4 | | $ | 1,071.9 | | $ | 3,229.6 | | $ | 3,010.5 | | Analytical Instruments | | | 778.5 | | | 786.5 | | | 2,282.9 | | | 2,349.8 | | Specialty Diagnostics | | | 776.9 | | | 811.8 | | | 2,379.2 | | | 2,480.6 | | Laboratory Products and Services | | | 1,638.2 | | | 1,628.7 | | | 4,844.9 | | | 4,918.6 | | Eliminations | | | (150.8) | | | (127.5) | | | (423.7) | | | (362.7) | | | | | | | | | | | | | | | | | | Consolidated revenues | | | 4,123.2 | | | 4,171.4 | | | 12,312.9 | | | 12,396.8 | | | | | | | | | | | | | | | | Segment Income (a) | | | | | | | | | | | | | | Life Sciences Solutions | | | 332.7 | | | 306.3 | | | 954.9 | | | 850.0 | | Analytical Instruments | | | 146.5 | | | 137.8 | | | 407.8 | | | 399.1 | | Specialty Diagnostics | | | 204.9 | | | 224.3 | | | 646.2 | | | 681.7 | | Laboratory Products and Services | | | 249.6 | | | 246.6 | | | 731.7 | | | 738.3 | | | | | | | | | | | | | | | | | | Subtotal reportable segments (a) | | | 933.7 | | | 915.0 | | | 2,740.6 | | | 2,669.1 | | | | | | | | | | | | | | | | | Cost of revenues charges | | | (0.8) | | | (2.1) | | | (2.5) | | | (326.7) | | Selling, general and administrative charges, net | | | (24.6) | | | (20.3) | | | (35.4) | | | (118.0) | | Restructuring and other (costs) income, net | | | (15.5) | | | 110.6 | | | (67.9) | | | 631.9 | | Amortization of acquisition-related intangible assets | | | (329.9) | | | (362.9) | | | (988.8) | | | (992.4) | | | | | | | | | | | | | | | | | | Consolidated operating income | | | 562.9 | | | 640.3 | | | 1,646.0 | | | 1,863.9 | | Other expense, net (b) | | | (94.8) | | | (101.1) | | | (292.3) | | | (313.8) | | | | | | | | | | | | | | | | | Income from continuing operations before income taxes | | $ | 468.1 | | $ | 539.2 | | $ | 1,353.7 | | $ | 1,550.1 | | | | | | | | | | | | | | | | Depreciation | | | | | | | | | | | | | | Life Sciences Solutions | | $ | 38.4 | | $ | 37.1 | | $ | 106.7 | | $ | 97.4 | | Analytical Instruments | | | 9.9 | | | 9.4 | | | 28.6 | | | 29.0 | | Specialty Diagnostics | | | 18.8 | | | 19.4 | | | 54.6 | | | 57.4 | | Laboratory Products and Services | | | 30.7 | | | 26.9 | | | 85.0 | | | 79.9 | | | | | | | | | | | | | | | | Consolidated depreciation | | $ | 97.8 | | $ | 92.8 | | $ | 274.9 | | $ | 263.7 | | | | | | | | | | | | | | | | (a) | Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles. | | (b) | The company does not allocate other expense, net to its segments. | | | | | | | | | | | | | | | |
|